Evidence map›Paper›PMID 35948978›Full record

ArticleDiabetology & metabolic syndrome2022

An affordable approach to classifying type 2 diabetes based on fasting plasma glucose, TyG index and BMI: a retrospective cohort study of NHANES Data from 1988 to 2014.

Jing Xie, Xin Zhang, Hua Shao, Shenqi Jing, Tao Shan, Yaxiang Shi, Yong Li, Yun Liu, Naifeng Liu

Abstract read
In one paragraph

Article in Diabetology & metabolic syndrome, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Common metabolic features of hypertension and type 2 diabetes.Hypertension research : official journal of the Japanese Society of Hypertension · 2023
    Review
  6. Association of Dietary Inflammation Index andMediators of inflammation · 2023
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jing XieCollege of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 210009, Jiangsu, China.
Xin ZhangDepartment of Information, The First Affiliated Hospital, Nanjing Medical University, Nanjing, 210029, Jiangsu, China.
Hua ShaoDepartment of Pharmacy, School of Medicine, Zhongda Hospital, Southeast University, Nanjing, 210009, Jiangsu, China.
Shenqi JingDepartment of Information, The First Affiliated Hospital, Nanjing Medical University, Nanjing, 210029, Jiangsu, China.
Tao ShanDepartment of Medical Informatics, School of Biomedical Engineering and Informatics, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
Yaxiang ShiDepartment of Information, School of Medicine, Zhongda Hospital, Southeast University, Nanjing, 210009, Jiangsu, China.
Yong LiDepartment of Cardiology, The First Affiliated Hospital, Nanjing Medical University, Nanjing, 210029, Jiangsu, China.
Yun LiuDepartment of Medical Informatics, School of Biomedical Engineering and Informatics, Nanjing Medical University, Nanjing, 211166, Jiangsu, China. liuyun@njmu.edu.cn.
Naifeng LiuCollege of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 210009, Jiangsu, China. liunf@seu.edu.cn.

Funding

The Industrial and Information Industry Transformation and Upgrading Special Fund of Jiangsu Province in 2018 [2019]55The Industrial and Information Industry Transformation and Upgrading Special Fund of Jiangsu Province in 2021 [2021]92The industry prospecting and common key technology key projects of Jiangsu Province Science and Technology Department BE2020721The National Key Research & Development Plan of Ministry of Science and Technology of China 2018YFC1314900The National Key Research & Development Plan of Ministry of Science and Technology of China 2018YFC1314901
6 · The paper itself

Abstract

backgroundThe β-cell function and insulin resistance required by existing methods of classifying type 2 diabetes are not routinely adopted in most medical institutions of developing countries and regions. This study aims to propose a novel, affordable classification approach and evaluate its predictive ability for several health and mortality outcomes, including cardiovascular health (CVH), retinopathy, chronic kidney disease (CKD), nonalcoholic fatty liver disease (NAFLD), advanced liver fibrosis, and mortality caused by all-cause, cardiovascular disease (CVD), cancer.

methodsBased on 4060 participants with diabetes (aged ≥ 30 at the time of diagnosis) selected from the National Health and Nutrition Examination Survey III & 1999-2014, we proposed a novel, but simple classification approach based on the threshold of fasting plasma glucose (FPG), triglyceride-glucose (TyG) index and body mass index (BMI). We used logistic regression model to assess its predictability for diabetes complications, and Cox regression model to estimate the mortality risks.

resultsBy utilizing this approach, we characterized the subjects into four subgroups: subgroup A (obesity-related), which accounts for 37% of the total, subgroup B (age-related), 38%, subgroup C (insulin resistance), 20%, and subgroup D (severe insulin deficiency), 5%. Subjects in subgroup D had a higher risk of retinopathy, in subgroup B had a lower risk of poor cardiovascular health, nonalcoholic fatty liver disease, and advanced liver fibrosis, in subgroup C had a higher risk of all-cause mortality.

conclusionsThis study proposes an affordable and practical method for classifying patients with type 2 diabetes into different subgroups, with a view to yield a high predictability of patient outcomes and to assist clinicians in providing better treatment.

Indexed as

AffordablePredictabilitySubgroupType 2 diabetes

Identifiers

PMID35948978
PMCPMC9364489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.